Concord Biotech Limited IPO Message Board (Page 46)

I my opinion , financials are poor, doesnt justify this valuation considering inconsistent results (no significant growth in bottom line).
GMP of 320 -330 not sustainable

Sahi bola apne

Poor topline and bottomline growth doesn’t justify even issue price.
Market cap of over 7500 crore at issue price is too much.
Any premium over and above issue price is highly overpriced.
In long run ( if not on listing), in my opinion, the share will be available at a discount to issue price.

250 seller

is it possible to earn FDR interest on money used for IPO application. If yes how.

Bhai Bank Pagal Nahi hai ki Aisa karegi

चीत भी मेरी और पट भी मेरी !
ऐप्लीकेशन लगाकर देख लो!
शायद बैंक का कम्प्यूटर बाबा कोई मेहरबानी करदे!

In stock market there is no rule for success. For each different company there may be different rules & parameters . As long as you are earning from the market / any specific stock it's good even though the Valuations/ Revenue / profit / Margin nothing matters. Only it's market price is important. In Stock Market the BHHAV is Bhagwan ( God)

Few months back Remus Pharma' ipo @ 1229 , which is today 4221/with multiplication of 73.
It's Other
Rev: 45 cr
Net Profit :8.50

If someone compares this with Market leader Dr Reddy or Divis Lab then the current price can not be justified. But it's the reality that it's trading @ 4221/
Here in Concord Biotech too, one may not compare it with others as long as it's giving good gain. Just like Cricket match runs are important but how you make it isn't important. 😀😃😄😆. Only Profit matters here.

Concord Biotech IPO
CMP (Issue Price + GMP)
= 741+264 = 1,005
EPS FY’23 = 22.95
PE = 43.79X

Divi’s Laboratories
CMP = 3,700
EPS FY’23 = 68.69
PE = 53.64

Divis labs revenue 10x as compared to concord. But yes, small companies mean room for growth which is not the case for big ones.

Eagleye G & Ujwal G

We should apply with full force/ only for listing gain or not ?

Please reply🙏🙏

@B.M.SURANA  ji please update GMP please..and also advise can we buy at this gmp?

@Jainsahab 
Ji Grey market [ Gujarat Ahmedabad, ] Se hi operates hota hai.
Ahmedabad mein hi dekho koi grey market wala.

Raipur Kolkata Beawar
GMP-
₹150/= ₹155/=

This company is near my home.
a good company but valuation in high compared to peers.company is good though.will decide appling after price band and GMP

It is proven history, Rakesh jhunjhoonwala backed companies do not perform well after listing.

Example A2Z maintenance and start health insurance.

I am holding 100 shares of Concord drugs

@newgen consultancy I am just sharing RJ IPO bound companies performance. RJ name does not give guarantee in IPO performance.

Even I will apply in Concord if its subscription number will be good and will command a healthy premium.

Global Presence. Export More than 70 Country. Year to Year Revenue Growth Positive. FY 2020-21 630+ Cr., FY 2021-22 736+ Cr. & FY 2022-23 888+ Cr & Profit Growth is Positive FY 2020-21 235 Cr, FY 2022-23 240+ Cr. & Main Positive side of Concord Biotech, Company Borrowing is Reduce year to year. Total Borrowing FY 2020-21 Rs. 86.35 Cr., FY 2021-22 Rs. 60.59 Cr. & FY 2022-23 Rs. 31.24 Cr. Very Positive.

Good info

Thanks for sharing

Superb Company. Global Presence. Company has Immunosuppressant (Tacrolimus, Mycophenolate Mofetil) Medicine World Market Share up to Approx 80 to 85 present. World Market Leader for Immunosuppressant Medicine. Company has Own Research Center. Dholka Plant facility is spread over 596,309 square meters & Valthera, Ahmedabad Plant is spread over 94,826 square meters.

Concord Biotech Limited IPO Final

Date : 04-Aug to 08-Aug-2023
FV : ₹1
Price : ₹705 - ₹741
Market Lot : 20 Shares
App Amt : ₹14,820
Size : ₹1,550.52 Cr
EMP : 0.67 Cr
Retail Form : 366,024
HNI Small Form : 3,735
HNI Big Form : 7,470
QIB : 50%
NII : 15%
Retail : 35%
Listing At : BSE, NSE
Registrar : Link Intime
Allotment : 14-Aug-2023
Listing : 18-Aug-2023

Allotment on 11 August please correct

CONCORD BIOTECH IPO

Date : 4-8 Aug
Size : 1569.4 cr ( OFS )
Price band : 705-741
M.cap post issue : 7755 cr
PE : 32.68
Listing : 17 Aug
Retail : 35%Employee discount: Rs.70

Selling shareholder : Helix investments

Peers-
1.Divis Lab : 54.37
2.Gland Pharma : 27.33.Glenmark Life : 16.2
4.Suven Pharma : 30.6
5.Laurus Labs : 23.03
6.Shilpa Medicare : Nil
7.Natco Pharma: 21.10

Facts : 1. Concord biotech's biggest rival globally is Almac Group (UK) which recently concluded its IPO in South Korean Markets
Which skyrocketed by 12% after info of Concord biotech's IPO , maybe a COINCIDENCE

2.Rakesh Jhunjhunwala's Family owns 24.09% equity of the company who are highest equity holder after promoter
Sudhir Vaid ( 28.84% )

Biotech for Mankind! Is this company part of Mankind Pharma?

I'm not impressed with growth rate and feel that valuation is over the roof. But enjoy listing gains.

Yesterday GMP close around 324/-
Lets check where it will open today.

sHni :- 2700/-
bHni :- 12700/-
Retail:- 875/-

Retail : 6 - 7 X
shni : 16 x
bhni : 9 x

At current premium above estimate is higher side.

Price Band : ₹705-₹741

Buyer 330/-

Anyone receive third party asba applications allotment or not ............in linkintime or kfintech or hoth
Are linkintime or kfintech both giving third party allotments. ...pls reply

TENTATIVE

Ebixcash IPO possible in Mid August

Size 5000 - 6000 crore

EBIXCASH kaisa rahega.. Any GMP... I think chances of allotment is much better due to bigger issue but listing gain hoga ke nahin

@Palka Grey market action will start soon maybe from tomorrow , more details to come
I expect price band around 235

I am personally very bullish ON EBIXCASH
Going to keep it in my portfolio for long term

I would like to be a part of India's growth story at a global prospects .

In COVID when travel business was shut , still
Ebixcash grey at a good CAGR and also finished positive bottomline
Consider this and the next fiscal , whole world is welcoming travel , see the company's future growth, If PE comes below 45 I am very comfortable and if above 45 then will review

TENTATIVE

Ebixcash IPO possible in Mid August

Size 5000 - 6000 crore